Status:
RECRUITING
Off-label Use of Anti-cancer Drugs in Norway -a Prospective Cohort Study
Lead Sponsor:
Oslo University Hospital
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Off-label drug use, where a marketed drug is used outside its approved indication, may allow early access to new and promising treatments. However, its use can be a source of controversy, due to limit...
Eligibility Criteria
Inclusion
- Verified cancer diagnosis (based on radiological, histological/cytological or operative evidence).
- Treatment with off-label anti-cancer drug.
- Age ≥ 18 years
- Able to provide written informed consent.
Exclusion
- None
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04457713
Start Date
June 1 2020
End Date
December 31 2027
Last Update
August 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Norway, 0379